{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:04:22Z","timestamp":1790823862115,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jpag.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T12:27:55Z","timestamp":1473424075000},"page":"562-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-7588","authenticated-orcid":false,"given":"Mohsen","family":"Rezaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasna","family":"Pouralborz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Ghodrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2016.07.001_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2016.07.001_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jpag.2016.07.001_bib3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/humrep\/des039","article-title":"Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome","volume":"27","author":"Kim","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2016.07.001_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jpag.2016.07.001_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jpag.2016.07.001_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jpag.2016.07.001_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2016.07.001_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cen.12068","article-title":"Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study","volume":"78","author":"Mani","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2016.07.001_bib9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl","key":"10.1016\/j.jpag.2016.07.001_bib10","first-page":"S8","article-title":"(2) Classification and diagnosis of diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2016.07.001_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2.1.13","article-title":"Polycystic ovarian syndrome: diagnosis and management","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jpag.2016.07.001_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib13","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.jpag.2016.07.001_bib14","first-page":"5872","article-title":"Effect of overweight\/obesity on IVF-ET outcomes in chinese patients with polycystic ovary syndrome","volume":"7","author":"Huang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/ybeog.2003.0348","article-title":"Acne and hirsuties in teenagers","volume":"17","author":"Barth","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jpag.2016.07.001_bib16","doi-asserted-by":"crossref","first-page":"797681","DOI":"10.1155\/2014\/797681","article-title":"The role of metformin in metabolic disturbances during pregnancy: polycystic ovary syndrome and gestational diabetes mellitus","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib17","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1589\/jpts.27.2293","article-title":"Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study","volume":"27","author":"Turan","year":"2015","journal-title":"J Phys Ther Sci"},{"key":"10.1016\/j.jpag.2016.07.001_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2016.07.001_bib19","first-page":"1","article-title":"Polycystic ovary syndrome: how are obesity and insulin resistance involved?","volume":"24","author":"Lindheim","year":"2012","journal-title":"OBG Management"},{"key":"10.1016\/j.jpag.2016.07.001_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMcp1103643","article-title":"Clinical practice. Diagnosis of diabetes","volume":"367","author":"Inzucchi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib21","first-page":"391","article-title":"Oral glucose tolerance testing","volume":"41","author":"Phillips","year":"2012","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.jpag.2016.07.001_bib22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and\u00a0impaired glucose tolerance implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2016.07.001_bib24","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome 1","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2016.07.001_bib25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/humrep\/det002","article-title":"Assessment of impaired glucose tolerance prevalence with hemoglobin A(1)c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study","volume":"28","author":"Celik","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2016.07.001_bib26","first-page":"45","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"4","author":"Roe","year":"2011","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.jpag.2016.07.001_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/science.635569","article-title":"The glycosylation of hemoglobin: relevance to diabetes mellitus","volume":"200","author":"Bunn","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.jpag.2016.07.001_bib28","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/dc10-1180","article-title":"High-normal HbA1c is a strong predictor of type 2 diabetes in the general population","volume":"34","author":"Bonora","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2016.07.001_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diacare.23.2.187","article-title":"Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population","volume":"23","author":"Rohlfing","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2016.07.001_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/dc11-1465","article-title":"Quantifying the effect of metformin treatment and dose on glycemic control","volume":"35","author":"Hirst","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2016.07.001_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/193229680900300402","article-title":"The clinical use of hemoglobin A1c","volume":"3","author":"Saudek","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jpag.2016.07.001_bib32","first-page":"278","article-title":"Prevalence of elevated glycated hemoglobin concentrations in the polycystic ovary syndrome: anthropometrical and metabolic relationship in amazonian women","volume":"6","author":"de Medeiros","year":"2014","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.jpag.2016.07.001_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/09513590.2013.788634","article-title":"Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome","volume":"29","author":"Pau","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2016.07.001_bib34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.fertnstert.2011.08.035","article-title":"Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome","volume":"96","author":"Velling Magnussen","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2016.07.001_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.12891\/ceog16312014","article-title":"Effect of HbA1C detection on the diagnostic screening for glucose metabolic disorders in polycystic ovary syndrome","volume":"41","author":"Zhen","year":"2014","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.jpag.2016.07.001_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.fertnstert.2011.07.002","article-title":"Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome","volume":"96","author":"Hurd","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2016.07.001_bib37","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/humrep\/det255","article-title":"Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method","volume":"28","author":"Lerchbaum","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2016.07.001_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jadohealth.2013.12.020","article-title":"Diagnosing dysglycemia in adolescents with polycystic ovary syndrome","volume":"55","author":"Gooding","year":"2014","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2016.07.001_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12902-015-0039-9","article-title":"HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome","volume":"15","author":"Odsaeter","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jpag.2016.07.001_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4158\/EP12123.OR","article-title":"Utility of hemoglobin-A1C in nondiabetic women with polycystic ovary syndrome","volume":"19","author":"Mortada","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jpag.2016.07.001_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0034-1377043","article-title":"Is glycated hemoglobin related to other dysmetabolic variables implicated in the increase of cardiovascular risk in polycystic ovary syndrome? A comparative study","volume":"122","author":"de Medeiros","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jpag.2016.07.001_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diab.41.2.202","article-title":"Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study","volume":"41","author":"Singer","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.jpag.2016.07.001_bib43","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","author":"Pertynska-Marczewska","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.jpag.2016.07.001_bib44","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/humrep\/dev195","article-title":"Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features","volume":"30","author":"Daan","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2016.07.001_bib45","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1210\/en.2015-1159","article-title":"Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of polycystic ovary syndrome (PCOS)","volume":"156","author":"Hurliman","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpag.2016.07.001_bib46","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/00004872-199508001-00011","article-title":"Risk factors for non-insulin-dependent diabetes mellitus","volume":"13","author":"Haffner","year":"1995","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.jpag.2016.07.001_bib47","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/diacare.21.4.518","article-title":"Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2016.07.001_bib48","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2016.07.001_bib49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4158\/EP13414.OR","article-title":"Practice patterns in screening for metabolic disease in women with PCOS of diverse race-ethnic backgrounds","volume":"20","author":"Mott","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jpag.2016.07.001_bib50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bpobgyn.2014.11.001","article-title":"Polycystic ovaries and obesity","volume":"29","author":"Messinis","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jpag.2016.07.001_bib51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.trsl.2015.08.011","article-title":"Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction","volume":"167","author":"Khodabandeloo","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.jpag.2016.07.001_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/dme.12560","article-title":"Relationship of hyperinsulinaemia, insulin resistance and beta-cell dysfunction with incident diabetes and\u00a0pre-diabetes: the Tehran Lipid and Glucose Study","volume":"32","author":"Derakhshan","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: current perspectives","volume":"7","author":"Palomba","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.jpag.2016.07.001_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment","volume":"93","author":"Heutling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2016.07.001_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-09-0432","article-title":"Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome","volume":"161","author":"Wehr","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jpag.2016.07.001_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/09513590.2011.583956","article-title":"Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome","volume":"28","author":"Costa","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2016.07.001_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and polycystic ovary syndrome","volume":"65","author":"Barber","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2016.07.001_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajpa.10364","article-title":"Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women","volume":"124","author":"Horejsi","year":"2004","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.jpag.2016.07.001_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(16)55249-2","article-title":"Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations","volume":"58","author":"Dale","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2016.07.001_bib60","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2016.07.001_bib61","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1474-4422(05)70227-1","article-title":"Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"4","author":"Selvin","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpag.2016.07.001_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2478\/v10255-012-0045-x","article-title":"High-sensitivity C-reactive protein in patients with polycystic ovary syndrome","volume":"19","author":"Iuhas","year":"2012","journal-title":"Romanian Journal of Diabetes Nutrition and Metabolic Diseases"},{"key":"10.1016\/j.jpag.2016.07.001_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2265.1997.1200936.x","article-title":"Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters","volume":"46","author":"Chapman","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2016.07.001_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1994.tb02577.x","article-title":"Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2016.07.001_bib65","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2016.07.001_bib66","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-07-0515","article-title":"Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome","volume":"158","author":"Cupisti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jpag.2016.07.001_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jpag.2016.07.001_bib68","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318816300948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318816300948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:44:02Z","timestamp":1761054242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318816300948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1083318816300948"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2016.07.001","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}